Navtemadlin,Ruxolitinib
Kartos Therapeutics,novartis,incyte
['mpnsm', '#mpn', 'navtemadlin', 'rux,(-crux),(-trux),(-deruxtecan)', 'rux,(-crux),(-trux)']
congress|#eha2023 john mascarenhas presents results from a global phase 1b/2 study investigating adding navtemadlin to rux for the treatment of mf. 64% of pts achieved svr-25, 45% achieved svr-35, and 55% achieved tss-50 #mpn #mpnsm #medicalcongress 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm